BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26132828)

  • 1. Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase.
    Goulas T; Mizgalska D; Garcia-Ferrer I; Kantyka T; Guevara T; Szmigielski B; Sroka A; Millán C; Usón I; Veillard F; Potempa B; Mydel P; Solà M; Potempa J; Gomis-Rüth FX
    Sci Rep; 2015 Jul; 5():11969. PubMed ID: 26132828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
    Zhao C; Ling B; Dong L; Liu Y
    Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
    Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
    Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
    Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
    Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
    Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
    J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
    Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
    Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
    Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
    Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Secreted Bacterial Peptidylarginine Deiminase Can Neutralize Human Innate Immune Defenses.
    Stobernack T; du Teil Espina M; Mulder LM; Palma Medina LM; Piebenga DR; Gabarrini G; Zhao X; Janssen KMJ; Hulzebos J; Brouwer E; Sura T; Becher D; van Winkelhoff AJ; Götz F; Otto A; Westra J; van Dijl JM
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
    Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
    Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
    Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis.
    Gabarrini G; de Smit M; Westra J; Brouwer E; Vissink A; Zhou K; Rossen JW; Stobernack T; van Dijl JM; van Winkelhoff AJ
    Sci Rep; 2015 Sep; 5():13936. PubMed ID: 26403779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.
    Gawron K; Bereta G; Nowakowska Z; Lazarz-Bartyzel K; Lazarz M; Szmigielski B; Mizgalska D; Buda A; Koziel J; Oruba Z; Chomyszyn-Gajewska M; Potempa J
    Mol Oral Microbiol; 2014 Dec; 29(6):321-32. PubMed ID: 25176110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved Citrullinating Exoenzymes in Porphyromonas Species.
    Gabarrini G; Chlebowicz MA; Vega Quiroz ME; Veloo ACM; Rossen JWA; Harmsen HJM; Laine ML; van Dijl JM; van Winkelhoff AJ
    J Dent Res; 2018 May; 97(5):556-562. PubMed ID: 29298553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis.
    Gabarrini G; Palma Medina LM; Stobernack T; Prins RC; du Teil Espina M; Kuipers J; Chlebowicz MA; Rossen JWA; van Winkelhoff AJ; van Dijl JM
    Virulence; 2018 Jan; 9(1):456-464. PubMed ID: 29505395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).
    Maresz KJ; Hellvard A; Sroka A; Adamowicz K; Bielecka E; Koziel J; Gawron K; Mizgalska D; Marcinska KA; Benedyk M; Pyrc K; Quirke AM; Jonsson R; Alzabin S; Venables PJ; Nguyen KA; Mydel P; Potempa J
    PLoS Pathog; 2013 Sep; 9(9):e1003627. PubMed ID: 24068934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.
    Laugisch O; Wong A; Sroka A; Kantyka T; Koziel J; Neuhaus K; Sculean A; Venables PJ; Potempa J; Möller B; Eick S
    Clin Oral Investig; 2016 May; 20(4):675-83. PubMed ID: 26264638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.
    Bielecka E; Scavenius C; Kantyka T; Jusko M; Mizgalska D; Szmigielski B; Potempa B; Enghild JJ; Prossnitz ER; Blom AM; Potempa J
    J Biol Chem; 2014 Nov; 289(47):32481-7. PubMed ID: 25324545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dropping anchor: attachment of peptidylarginine deiminase via A-LPS to secreted outer membrane vesicles of Porphyromonas gingivalis.
    Gabarrini G; Heida R; van Ieperen N; Curtis MA; van Winkelhoff AJ; van Dijl JM
    Sci Rep; 2018 Jun; 8(1):8949. PubMed ID: 29895934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
    Vitkov L; Hannig M; Minnich B; Herrmann M
    Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.